10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2023-05-15 (Q1 2023) | Holdings: 59 | Value: $4.4B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S | 16.89% | $745.9M | +88.20% | -4.71% | +30.17% | ||
| PCVX - VAXCYTE INC | Add 24% ($53.7M) | 6.19% | $273.3M | -29.73% | -4.24% | +52.36% | |
| DICE - DICE THERAPEUTICS INC | Add 15% ($28.9M) | 5.10% | $225.1M | ||||
| ETNB - 89BIO INC | Add 27% ($37.5M) | 3.94% | $173.9M | -41.41% | -5.47% | -47.24% | |
| AVTE - AEROVATE THERAPEUTICS INC | 3.77% | $166.7M | -26.02% | +8.20% | |||
| BIIB - BIOGEN INC | 3.35% | $148.2M | -58.03% | -14.60% | -25.94% | ||
| VRNA - VERONA PHARMA PLC | 2.87% | $126.9M | +316.86% | -12.77% | -34.89% | ||
| CTKB - CYTEK BIOSCIENCES INC | 2.78% | $123.0M | -53.29% | +16.85% | -13.57% | ||
| VOR - VOR BIOPHARMA INC | 2.77% | $122.4M | -95.13% | -36.38% | -60.78% | ||
| LEGN - LEGEND BIOTECH CORP | 2.66% | $117.5M | -56.75% | -7.05% | -36.29% | ||
| TYRA - TYRA BIOSCIENCES INC | 2.63% | $116.3M | -20.36% | +16.60% | +49.57% | ||
| JANX - JANUX THERAPEUTICS INC | 2.38% | $104.9M | +110.90% | -4.77% | +304.68% | ||
| PEPG - PEPGEN INC | 2.25% | $99.5M | -90.35% | -58.76% | -7.27% | ||
| RNA - AVIDITY BIOSCIENCES INC | Add 18% ($14.8M) | 2.23% | $98.5M | +222.08% | -24.07% | +159.91% | |
| RYTM - RHYTHM PHARMACEUTICALS INC | 2.23% | $98.4M | +300.36% | +54.02% | +136.96% | ||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | 2.13% | $94.1M | -48.25% | +0.15% | +19.36% | ||
| BLU - BELLUS HEALTH INC NEW | Add 2% ($1.4M) | 2.06% | $91.0M | ||||
| CVAC - CUREVAC N V | New Purchase | 1.93% | $85.4M | -49.66% | +6.21% | -60.72% | |
| IMGN - IMMUNOGEN INC | 1.90% | $83.9M | +22.82% | ||||
| WVE - WAVE LIFE SCIENCES LTD | 1.69% | $74.5M | +68.75% | +7.50% | +47.50% | ||
| INBX - INHIBRX INC | 1.65% | $72.7M | |||||
| GERN - GERON CORP | Add 144% ($40.4M) | 1.55% | $68.5M | -47.83% | -9.70% | +30.43% | |
| COGT - COGENT COMMUNICATIONS HLDGS | 1.47% | $64.7M | -48.45% | +1.46% | -35.71% | ||
| CLDX - CELLDEX THERAPEUTICS INC NEW | Reduce 16% $(12.2M) | 1.41% | $62.4M | -41.74% | -10.05% | +19.15% | |
| ACRV - ACRIVON THERAPEUTICS INC | 1.38% | $61.0M | -91.17% | -20.48% | -39.55% | ||
| ITOS - ITEOS THERAPEUTICS INC | 1.36% | $60.1M | -30.89% | -21.59% | +21.52% | ||
| NAMS - NEWAMSTERDAM PHARMA COMPANY | 1.20% | $53.0M | +59.53% | -9.81% | +63.94% | ||
| VRDN - VIRIDIAN THERAPEUTICS INC | Add 128% ($28.7M) | 1.16% | $51.1M | -38.14% | -15.55% | -36.45% | |
| RXST - RXSIGHT INC | 1.15% | $50.9M | -33.60% | +34.76% | +177.08% | ||
| MLYS - MINERALYS THERAPEUTICS INC | New Purchase | 1.13% | $49.8M | -7.96% | -27.99% | -22.51% | |
| PLRX - PLIANT THERAPEUTICS INC | New Purchase | 1.06% | $46.9M | -92.71% | -22.07% | -29.27% | |
| ELVN - ENLIVEN THERAPEUTICS INC | New Purchase | 1.05% | $46.5M | +9.03% | -21.73% | +21.48% | |
| GHRS - GH RESEARCH PLC | Add 14% ($5.5M) | 1.01% | $44.6M | +17.96% | +2.81% | +19.08% | |
| ABOS - ACUMEN PHARMACEUTICALS INC | 0.90% | $39.7M | -82.26% | +12.60% | -38.14% | ||
| ELYM - ELIEM THERAPEUTICS INC | 0.86% | $38.1M | -57.33% | -9.84% | +181.49% | ||
| ANTX - AN2 THERAPEUTICS INC | 0.84% | $37.2M | -79.74% | +68.80% | -58.58% | ||
| ALPN - ALPINE IMMUNE SCIENCES INC | Add 7% ($2.2M) | 0.82% | $36.2M | +55.40% | +662.44% | ||
| ACRS - ACLARIS THERAPEUTICS INC | 0.81% | $35.6M | -80.95% | -5.74% | -85.59% | ||
| ICVX - ICOSAVAX INC | 0.78% | $34.6M | -15.23% | ||||
| FULC - FULCRUM THERAPEUTICS INC | Add 22% ($6.0M) | 0.75% | $33.1M | +96.41% | +12.71% | +115.33% | |
| HLVX - HILLEVAX INC | 0.66% | $29.1M | -85.90% | -15.11% | +12.01% | ||
| NKTX - NKARTA INC | 0.63% | $27.7M | -59.78% | -56.92% | +49.89% | ||
| KNTE - KINNATE BIOPHARMA INC | 0.60% | $26.7M | -44.63% | ||||
| NSTG - NANOSTRING TECHNOLOGIES | New Purchase | 0.55% | $24.3M | -65.01% | -98.20% | ||
| SPRY - ARS PHARMACEUTICALS INC | 0.44% | $19.6M | +74.32% | -11.02% | +18.03% | ||
| RCKT - ROCKET PHARMACEUTICALS INC | Reduce 53% $(21.8M) | 0.44% | $19.4M | -87.01% | -26.02% | +9.70% | |
| TNYA - TENAYA THERAPEUTICS INC | 0.39% | $17.3M | -92.17% | -44.35% | -38.41% | ||
| DSGN - DESIGN THERAPEUTICS INC | 0.39% | $17.1M | -39.94% | -68.02% | -32.43% | ||
| SLDB - SOLID BIOSCIENCES INC | 0.37% | $16.2M | -32.11% | -39.94% | +48.56% | ||
| HOWL - WEREWOLF THERAPEUTICS INC | New Purchase | 0.36% | $16.0M | -55.11% | -3.65% | +78.10% | |
| SCPH - SCPHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| AKRO - AKERO THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| CELC - CELCUITY INC | Reduce 100% | 0.00% | $0.00 | ||||
| DALS - DA32 LIFE SCNCE | Reduce 100% | 0.00% | $0.00 | ||||
| ELVN - IMARA INC | Reduce 100% | 0.00% | $0.00 | ||||
| TVTX - TRAVERE THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||